n a bit more deliberate than Jazz, but is coming along nicely. Antares started its royalty deals with a gel based platform, one being a royalty deal with Actavis, Inc. (NYSE: ACT) (formely Watson Pharma) for topical oxybutynin gel. Oxybutynin…
Tag: biopharma
Video: Halozyme 60 Minute, 10 Day Chart Analysis As Of Close, 9/16/13 – Sentiment = Bullish
Halozyme 60 Minute, 10 Day Chart Analysis As Of Close, 9/16/13 – Sentiment = Bullish
$HALO 1132 Sept calls bought at 7.50 strike.
$HALO just had 1132 Sept calls bought at 7.50 strike, someone knows something, therefore, I bought shares, looking for Monday Potential Gap. I’ve been buying, average about $7.60 or so. CHMP decision expected in Europe,. With that many calls taken…
Correction: Weekend Update: $MNKD + $SLTM My video commentary on what is really going on with Mannkind and Solta (Public Video)
Weekend Update: $MNKD + $SLTM. My video commentary on what is really going on with Mannkind and Solta
Scott’s Mid-Week Market Commentary For Week Aug 6 – 9/2013
Scott’s Mid-Week Market Commentary For Week Aug 6 – 9/2013. $ONTX $INSM $AEGR $AUXL plus commentary on Market conditions and current chatter concerning the latest “terrorist threats,” and more!
Trius Acquired Last Week, Tetraphase Could Be Next
Written by Scott Matusow, Mr.Matusow holds a position in the company featured in this article. Last week, Cubist Pharmaceuticals Inc. (CBST) agreed to buy Trius Therapeutics Inc. (TSRX) and Optimer Pharmaceuticals Inc. (OPTR) for as much as $1.62 billion. Cubist…
Biodel Video Chart Analysis
My Biodel Chart Analysis Video – StockMatusow.com ‘s price target opinion for this catalyst run-up trade is around $6
Significant Near Term Catalyst Should Further Rally Keryx Pharmaceuticals
Recently, we have detailed companies that have released positive Phase III data because we believe several of these companies continue to be under speculation value. Companies who have strong management, cash, and a strong pipeline can be very profitable for…
Video: Solta Inc. ($SLTM) Likely Acquisition:| Chart And Commentary
Solta Inc. ($SLTM) Chart And Commentary. My short term target price opinion is $3 or so. Commentary also included.
Public Video: | Market Wrap-Up and Commentary For 7.17.13 + Previewing 2 Upcoming Picks
Hi everyone, Scotty here with ya! In this video, I give my view on recent market action, my short/mid/long term forecast moving forward, Biotech stock commentary, and a preview of 2 picks from stockmatusow.com for next week. Premium members get…
